Jun 22, 2022· Comment from National Association of Chain Drug Stores (NACDS)· FDA-2022-N-0165-0174
Please see the attached comments of the National Association of Chain Drug Stores regarding the potential modification to the Opioid Analgesic Risk Evaluation and Mitigation Strategy (OA REMS) to require the provision of mail-back envelopes and education on safe disposal for opioid prescriptions dispensed in outpatient settings (FDA–2022–N–0165).